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1. Introduction 
When computed tomography started to be used routinely in the evaluation of patients 
presenting with seizures it became evident that some periictal abnormalities disappeared in 
follow-up studies with no specific treatment except antiepileptics. These findings suggested 
that those reversible abnormalities were not structural but functional, possibly resulting 
from the cerebral edema induced by seizure activity (Goulatia et al. 1987; Sammaritano et 
al., 1985; Sethi et al., 1985). 
With the advent of MRI and it’s increasingly use in the acute phase of seizures, these seizure-
induced abnormalities were also demonstrated, being described as periictal or reversible MRI 
abnormalities (Cole 2004; Briellmann et al., 2005); since follow-up MRI studies disclosed that 
irreversible brain damage can occur in the regions previously affected by them, they are now 
better defined as transient periictal MRI abnormalities (TPMA). In this way, TPMA should 
only be considered if two conditions are fulfilled: first, the brain MRI signal abnormalities 
demonstrated periictally must be attributable to seizures and not other causes; and second, 
that these abnormalities totally or partially reverse on subsequent MRI studies. Besides the 
detection of TPMA, MRI can provide us with a unique non-invasive diagnostic tool to better 
understand the physiopathological mechanisms underlying TPMA formation, and to identify 
and predict the brain damage induced by seizures. 
In this chapter, we review the neuroimaging features, differential diagnosis, 
pathophysiology, electroclinical-imagiological spectrum and outcome of TPMA, 
highlighting the fundamental role of multi-sequence MRI studies in their investigation.  
2. Clinical and electroencephalographic findings associated with TPMA 
TPMA have been described in several case reports (Amato et al., 2001; Bauer et al., 2006; 
Chu et al., 2001; Kramer et al., 1987; Senn et al., 2003) and small case series (Canas et al., 
2010a; Chan et al., 1996; Huang et al., 2009; Milligan et al., 2009; Raghavendra et al., 2007), 
the largest not including more than 20 patients (Canas et al., 2010b). This scarcity of reports 
contrast with the practice of clinicians involved in the evaluation of patients presenting with 
seizures, where is not so uncommon to find MRI abnormalities induced by them.  
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The exact incidence of TPMA is still unknown, with estimated values ranging from 0.007% 
(Raghavendra et al., 2007) to 29.4% (Huang et al., 2009). The best estimation of TPMA 
incidence that we presently have comes from a prospective study in which MRI was 
systematically obtained in 34 patients with status epilepticus, with TPMA being disclosed in 
20.6% of them (Goyal et al., 2009). Similar TPMA incidences were reported in the studies 
that retrospectively reviewed the MRI obtained from patients presenting with status 
epilepticus, with the periictal signal abnormalities presumably attributable to seizures 
described in 11.6% (Milligan et al., 2009) and 29.4% (Huang et al., 2009) of the patients. Since 
these results were obtained in patients presenting with status epilepticus, a condition 
associated with a higher likelihood of inducing TPMA (Cole, 2004), we think that they 
overestimate the real TPMA incidence, a supposition supported by the much lower values 
described in the overall population of patients hospitalized for the evaluation of seizure 
disorders (Raghavendra et al., 2007).     
In fact, and although TPMA have been more frequently described in convulsive status 
epilepticus, complex partial status epilepticus and seizures with a prominent motor 
component, they could be induced by virtually any type of seizure, a cluster of seizures or 
other forms of status epilepticus. TPMA can be disclosed in patients with presenting 
seizures provoked by systemic factors (such as alcohol withdrawal, infections or dialysis 
disequilibrium) or associated with structural cerebral pathologies, the most common being 
small-vessel cerebrovascular disease or post-traumatic/ post-stroke encephaloclastic lesions; 
and can also be demonstrated in patients with a previous history of epilepsy, often difficult 
to control focal symptomatic or probably symptomatic epilepsies.  
The electroencephalographic findings associated with TPMA are also vary variable, with the 
ictal electroencephalograms generally showing focal continuous or in crescendo epileptiform 
discharges, rhythmic activity or lateralized periodic epileptiform discharges; in postictal 
electroencephalograms, the most frequent findings are focal slowing with or without 
associated epileptiform discharges, lateralized or bilateral periodic epileptiform discharges, 
frontal intermittent rhythmic delta activity, or no relevant abnormalities.  
The reasons why TPMA occur in some but not all patients with seizures is still an 
unresolved issue. However, some critical variables have been proposed as determinants of 
TPMA occurrence or outcome, such as seizure type and duration, pre-existing brain lesions, 
pharmacological interventions (Cole, 2004) and possible hypoperfusion or hypoxia (Milligan 
et al., 2009). The disclosure of TPMA can also be determined by methodological factors, 
namely the MRI timing, with ictal or early postictal MRIs increasing the probability of their 
detection (Briellmann et al., 2005; Goyal et al., 2009). 
3. TPMA neuroimaging features 
TPMA may present with several MRI signal abnormalities, heterogeneous patterns and 
topographic distribution, contributing to wide neuroimaging features. The knowledge of 
these features is paramount to recognize TPMA and to make a proper differential diagnosis 
with other pathologies.  
3.1 Signal abnormalities 
To be visible on an MRI, the seizure-induced MRI abnormalities must be associated with a 
relatively widespread change in water environment (Briellmann et al., 2005). In this way, the 
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intra and/ or extracellular edema induced by seizures are generally hypointense in T1-
weighted imaging and hyperintense in fluid-attenuated inversion recovery (FLAIR) and T2-
weighted imaging, with restriction to water on diffusion-weighted imaging (DWI). A pial or 
cortico-pial contrast enhancement can also be disclosed, particularly in larger TPMAs with a 
subcortical component. In the cases in which a protonic magnetic resonance spectroscopy 
(MRS) was obtained periictally, the most consistent findings were an increase in the lactate 
levels and choline and a decrease in N-acetyl-aspartate (Castillo et al., 2001; Lazeyras et al., 
2000; Mueller et al., 2001), with the levels of myoinositol possibly fluctuating during and 
after seizures (Wellard et al., 2003). Generally, these signal abnormalities are colocalized in 
the same brain regions. 
Although the exact mechanisms underlying these seizure-induced MRI signal changes are 
still not well known, some have been proposed, mostly based on theoretical models or data 
from experimental studies (table 1). 
 
MRI sequence Measurement of 
Acute signal 
change 
Attributed to 
T1-weighted T1-signal Increase  Cell edema 
T2-wighted T2-signal Increase  Cell edema 
FLAIR FLAIR signal Decrease Cell edema 
DWI ADC 
Decrease  Cytotoxic edema 
Increase  Vasogenic edema 
Proton MRS 
Lactate  Increase Anaerobic metabolism 
N-acetyl-aspartate Decrease Neuronal loss/ dysfunction 
Choline Increase Increased membrane turnover 
Myoinositol Decrease Osmolyte changes 
With contrast 
Contrast 
enhancement  
Cortico-pial 
enhancement 
Hypervascularization, 
vasodilatation, breakdown of the 
blood-brain barrier 
Table 1. MRI signal abnormalities induced by seizures.  
Several authors highlighted the prominent role of DWI in disclosing TPMA (Kim et al., 2001; 
Szabo et al., 2005). DWI is the most sensitive MRI-sequence in detecting TPMA (restriction 
to water diffusion present in more than 90% of the cases), being frequently the only reliable 
signal abnormality in small TPMAs restricted to the cerebral cortex or in TPMAs bordering 
old encephaloclastic lesions (Canas et al., 2010b). In the cases in which attenuation diffusion 
coefficient (ADC) studies were obtained,  some authors reported an increased DWI signal 
with decreased diffusivity, compatible with cytotoxic edema (Chu et al., 2001; Parmar et al., 
2006; Szabo et al., 2005), and others a decreased DWI signal with increased diffusivity, 
disclosing vasogenic edema (Hong et al., 2004; Wieshmann et al., 1997); other authors, 
including ourselves, described diverse findings in the TPMA ADC studies, with some 
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patients showing a predominantly cytotoxic or vasogenic edema, while others having 
intermixed areas of both types of edema, mainly cortical cytotoxic edema and subcortical 
vasogenic edema (Canas et al., 2010a, 2010b; Kim et al., 2001).  
The timing of MRI acquisition has been proposed by some authors as one of the factors that 
could contribute to these apparently non-congruent findings regarding the TPMA ADC 
signal abnormalities (Briellmann et al., 2005; Hong et al., 2004). Animal experiments 
disclosed that, early after a seizure, the lactate levels increase and the ADC values decrease, 
with these changes attributed to the failure of the Na+/K+-ATPase pump and anaerobic 
metabolism (Najm et al., 1997; Righini et al., 1994; Wang et al., 1996); whereas the lactate 
changes are short-lived, the ADC value is maximally decreased at 24 hours, returning to the 
control level or increasing in the following 48 to 72 hours, when T2-weighted abnormalities 
emerge (Nakasu et al., 1995; Righini et al., 1994). However, in clinical practice we can 
observe different MRI signal abnormalities, including increases and decreases in ADC 
values, in MRIs performed with similar timings regarding the seizure onset, disclosing that 
other factors must be considered. We believe that one of those factors is the diverse 
susceptibilities of different brain regions to the pathophysiological mechanisms involved in 
TPMA formation (see below).  
3.2 Topography and patterns  
The great majority of TPMAs are focal and unilateral, cortically restricted or with a cortico-
subcortical pattern. Although they can arise anywhere in the cerebral neocortex, they are 
commonly disclosed in the posterior and perirolandic regions or in the periphery of old 
encephaloclastic lesions (Silverstein & Alexander, 1998; Canas et al., 2010b). Less frequently 
they have a marked subcortical component, with mass effect and gyral effacement, 
mimicking an intracerebral neoplasm (Canas et al., 2010a; Cohen-Gadol et al., 2004; 
Hicdonmez et al., 2003); are more diffuse or bilateral; or are associated with remote signal 
abnormalities, affecting structures anatomically distant from the neocortical seizure focus, 
including the contralateral cerebellar hemisphere (cerebellar diaschisis), thalamus (more 
frequently the pulvinar), splenium of the corpus callosum, caudate and globus pallidus 
(Cole, 2004). In some cases, evanescent T2-weighted and DWI abnormalities are disclosed in 
cortical regions widely separated from the probable seizure focus, with the signal 
abnormalities of these migratory lesions and TPMA resolving almost simultaneously (Cole, 
2004; Raghavendra et al., 2007). Remote and migratory signal abnormalities are believed to 
result from seizure propagation through neuronal pathways, and are usually associated 
with larger neocortical TPMA.  
3.3 Classification 
The first classification for TPMA was proposed by Cole, who classified them into local 
(colocalized with the epileptic discharge) and remote (affecting distant structures) (Cole, 
2004). After that, two comprehensive classification systems to cover the broad spectrum of 
changes that comprise TPMA were proposed by us (Canas et al., 2010b) and other authors 
(Raghavendra et al., 2007). These two classifications are based mostly on TPMA patterns 
and signal abnormalities, facilitating their recognition by Neurologist and 
Neuroradiologists, and helping in their differential diagnosis. 
Raghavendra and colleagues classified TPMA into type I, restricted to the superficial gray 
matter; type II, affecting the superficial gray and subcortical white matter (type IIa) or with 
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the subcortical white matter involvement extending to the adjacent periventricular surface 
(type IIb); type III, with involvement of the subcortical nuclei associated with any degree of 
cortical or white matter involvement; type IV, involvement of white matter alone; and type 
V, with leptomeningeal enhancement and/ or gyriform cortical enhancement. Regarding the 
differential diagnosis, type I and IIa can mimic encephalitis, type IIb an intracerebral 
neoplasm and type V, due to the leptomeningeal involvement, meningoencephalitis; type IV 
can mimic several pathologies and in type V the ictal onset may have a poor localizing value 
(Raghavendra et al., 2007). 
Our classification has several similarities to the classification proposed by Raghavendra and 
colleagues (Raghavendra et al., 2007), although we did not find any TPMA restricted to the 
subcortical white matter (Canas et al., 2010b). We classified TPMA into type 1, restricted to 
the cerebral cortex, and type 2, cortico-subcortical. Type 2 TPMA can further have a marked 
subcortical component with mass effect, mimicking a tumor lesion (type 2A- tumor-like); be 
in the periphery/ bordering an old encephaloclastic lesion (type 2B) or be associated with 
remote signal abnormalities (type 2C) (table 2).  
 
Type Characteristics  Main MRI features Major differential diagnosis 
1 Cortically restricted
Frequently only disclosed 
on DWI  
Small embolic stroke 
Creutzfeldt-Jacob disease 
2 Cortico-subcortical 
Any of the TPMA signal 
abnormalities 
Embolic stroke, Encephalitis, 
meningoencephalitis, venous 
thrombosis,  
2A 
Prominent 
subcortical 
component  
Mass effect, frequent 
contrast enhancement; 
marked vasogenic edema  
Intracerebral neoplasm, low 
grade gliomas 
2B 
Bordering an old 
encephaloclastic 
lesion 
Frequently only disclosed 
on DWI 
Small embolic stroke 
2C 
Associated with 
remote lesions 
Signal abnormalities in the 
contralateral cerebellum, 
or the homolateral 
pulvinar, caudate,  
pallidus 
Reversible posterior 
leukoencephalopathy 
syndrome, stroke, 
Creutzfeldt-Jacob disease 
Table 2. Proposed TPMA classification 
Topographically, the great majority of type 1, type 2A and 2B TPMA are focal and 
unilateral, while most type 2C are larger (hemispheric, lobar, multilobar) and/ or bilateral. 
Tumor-like TPMA are frequently disclosed in patients with presenting seizures without a 
known etiology and generally are associated with a good outcome (Canas et al., 2010a); 
conversely, type 2C generally occur in patients with a previous history of epilepsy, and are 
associated with a high percentage of clinical and MRI sequelae (Canas et al., 2010b). The 
factors predisposing patients with similar types and duration of seizures to develop 
different types of TPMA remain to be elucidated.  
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The wide spectrum of TPMA signal abnormalities, topography and patterns are shown in 
figures 1 to 7. To better understand our proposed TPMA classification, a clinical vignette is 
provided, including the outcome of the disclosed TPMA.  
 
 
 
 
 
 
Fig. 1. 56 year-old female patient with 3 left focal motor seizures in 1 hour, one with 
secondarily generalization; there was no history of epilepsy and the seizure etiology was 
undetermined. The periictal MRI disclosed a pseudotumoral lesion (type 2A TPMA) around 
the right marginal sulcus, hyperintense on FLAIR, hypointense on T1 and with a cortico-pial 
pattern of gadolinium (Gad) enhancement (arrow). There was no significant diffusion 
restriction, thus suggesting vasogenic edema. (*) The follow-up MRI at 2 months showed 
resolution of the edema and contrast enhancement, with cortical laminar necrosis in the 
previously affected region; in spite of this, there were no clinical or electroencephalographic 
sequels.   
 
 
 
 
 
 
Fig. 2. 45 year-old male patient, with two simple motor seizures affecting the left arm, one 
with secondarily generalization; he had a left hemiparesis due to previous stroke, but no 
history of epilepsy; the presenting seizures were induced by alcohol withdrawal. The 
periictal MRI disclosed an old right parietal ischemic stroke, surrounded by focal diffusion 
restriction (arrow), gadolinium (Gad) enhancement and FLAIR hyperintensity (type 2B 
TPMA), attributable to acute seizures and not to a new small embolic stroke. (*) The follow-
up MRI at 3 months showed resolution of the periictal signal abnormalities, although the 
patient developed de novo focal epilepsy and aggravated the pre-existing left hemiparesis. 
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Fig. 3. 73 year-old female patient presenting almost continuous clonic jerks of the left 
hemiface in the last 5 days; the etiology of the simple motor status epilepticus was attributed 
to small-vessel cerebrovascular disease. The periictal MRI disclosed a hyperintensity of the 
right precentral gyrus with subcortical involvement and mass effect on T2 and FLAIR, a T1-
weighted hypointensity, DWI restriction and no contrast enhancement; lesional MRS 
revealed a decrease in N-acetyl-aspartate (NAA) and an inverted lactate peak (type 2A 
TPMA). The Follow-up MRI after 60 months (B) shows resolution of the precentral signal 
abnormalities, with slight regional brain atrophy, mild recovery of the choline / N-Acetyl A 
ratio and lactate normalization on MRS. In spite of these residual MRI findings, there were 
no clinical or electroencephalographic sequels attributable to the TPMA. 
 
 
Fig. 4. 45 year-old male patient with consciousness impairment in the last 6 hours. The ictal 
electroencephalogram showed continuous epileptiform discharges over the left temporal 
region, diagnosing complex partial status epilepticus, attributed to alcohol withdrawal. The 
periictal MRI disclosed diffuse left hemisphere cortical swelling, T2 hyperintensity and 
diffusion restriction, associated with remote left pulvinar (arrow) T2 and DWI 
hyperintensity (type 2C TPMA). (*) The follow-up MRI at 5 months showed resolution of 
diffusion restriction signal abnormalities and edema, with marked focal atrophy and 
cortical-subcortical gliosis. The irreversible brain damage that resulted from the TPMA was 
responsible for Wernicke aphasia and de novo focal symptomatic epilepsy. 
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Fig. 5. 59 year-old female patient with a previous history of post-stroke epilepsy. In the last 3 
days she presented with stupor, with occasional nystagmoid eye jerks. The ictal EEG 
allowed the diagnosis of subtle status epilepticus, attributed to a change in the usual 
antiepileptic medication. The periictal MRI showed bilateral cortico-subcortical T2 and DWI 
hyperintensities involving the insula, frontal and temporal lobes, the cingulum, the 
hippocampus and the pulvinar (type 2C TPMA). (*) The follow-up MRI at 3 months showed 
resolution of diffusion restriction signal abnormalities and aggravation of the diffuse 
cerebral atrophy. After the status epilepticus control, the patient remained tetraparetic and 
died after 5 months.  
 
 
Fig. 6. 35 year-old male patient with cryptogenic refractory temporal lobe epilepsy. 
Consciousness impairment with occasional clonic jerks of the left arm in the last 2 days, with 
the ictal electroencephalogram diagnosing complex partial status epilepticus. The periictal 
MRI disclosed cortical-subcortical edema and signal changes of the entire right cerebral 
hemisphere, sparing the rolandic area, with cortical diffusion restriction and cortico-pial 
contrast enhancement; concomitant contra-lateral cerebellar hemisphere and tonsil signal 
changes (crossed cerebellar diaschisis) (type 2C TPMA). (*) The follow-up MRI at 5 months 
showed resolution of the edema and contrast enhancement, with cortico-subcortical T2 and 
FLAIR hyperintensities in the previously affected areas (demyelination and gliosis), and 
generalized brain atrophy, more marked at the right frontal lobe. After the status 
epilepticus, the patient developed a left hemiparesis.  
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Fig. 7. 78 year-old female patient with a previous history of hypertension and diabetes 
mellitus type II. Admitted with consciousness impairment and occasional jerks of the right 
arm in the last 3 days; the ictal electroencephalogram disclosed periodic lateralized 
epileptiform discharges with a higher amplitude over the left posterior regions; the 
diagnosis of complex partial status epilepticus was admitted, attributable to small-vessel 
cerebrovascular disease. The periictal MRI disclosed left parieto-occipital cortical diffusion 
restriction without significant signal changes in the other sequences (type 1 TPMA), which 
disappeared in follow-up MRIs. After few months, the patient developed de novo partial 
epilepsy easily controlled with antiepileptics. 
3.4 Differential diagnosis 
The difficult differential diagnosis between the lesions induced by seizures and other 
pathologies as been described since the earlier computed tomography descriptions 
(Silverstein & Alexander, 1998). In the MRI era those difficulties persisted, mostly due to the 
similar signal abnormalities disclosed on focal TPMA and other pathologies that may 
present with seizures, namely acute ischemic stroke, intracerebral tumors, reversible 
posterior leukoencephalopathy syndrome, encephalitis, and venous infarctions resulting 
from cerebral venous thrombosis.  
The differential diagnosis with all these pathologies is particularly relevant in a patient with 
a first seizure or presenting SE since the attending clinicians may assume that the observed 
MRI abnormalities are the cause and not the consequence of seizures, a supposition that 
may possibly lead to unnecessary diagnostic procedures. Although the clinical context in 
which seizures occur is fundamental to make a correct diagnosis, certain particularities 
resulting from a detailed MRI evaluation can also contribute for that.  
The differential diagnosis of TPMA with embolic acute stroke is mostly relevant, since both 
situations occur with a prominent cortico-subcortical water restriction on DWI studies. 
However, TPMA generally do not respect vascular territories, such as in acute stroke 
(Lansberg et al., 1999), and in uncertain cases a hyperperfusion demonstrated on perfusion 
computed tomography (Masterson et al., 2009) or MRI (Flacke et al., 2000; Szabo et al., 2005) 
favors TPMA, while hypoperfusion favors stroke. Other relevant differential diagnosis of 
TPMA, namely if they have a tumor-like appearance, is with low grade gliomas; in this 
situation, the results of the DWI studies are very helpful, with TPMA having a marked 
restriction to water diffusion, generally not present in low grade gliomas (Cha, 2006). 
Regarding encephalitis and venous infarctions resulting from cerebral venous thrombosis 
the differential diagnosis with TPMA can only be properly made after the CSF analysis and 
venous angiography, respectively, excluded these pathologies.  The patterns and signal 
abnormalities of TPMA are so similar to the ones observed in reversible posterior 
leukoencephalopathy syndrome that solely the clinical context in which they occur can help 
to make a proper differential diagnosis (Hinchey et al., 1996; Kozak et al., 2007). The same 
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applies to TPMA restricted to the cerebral cortex or associated with remote lesions, very 
similar to the MRI abnormalities observed in Creutzfeldt-Jacob disease (Meissner et al., 2008; 
Young et al., 2005).   
We must highlight that in some cases, and in spite of a detailed clinical history and MRI 
analysis, the differential diagnosis between TPMA and some of these pathologies can be 
very difficult. In these situations, the results of subsequent neuroimaging studies obtained 
some days after seizure control can be very helpful, with the disappearance of the 
abnormalities strongly favoring the diagnosis of TPMA.  
4. TPMA electroclinical-imagiological spectrum 
Although a high topographic concordance between the clinical, electroencephalographic 
and MRI findings have been described in most case reports, only recently large case series 
applied systematically these studies to determine the electroclinical-imagiological spectrum 
of TPMA. In a recent case series, Huang and colleagues reported an almost complete 
topographic concordance between the periictal MRI abnormalities and the electroclinical 
findings in 15 patients presenting with status epilepticus (Huang et al., 2009); similar 
findings were described in 10 patients with partial status epilepticus, with the periictal DWI 
abnormalities always colocalized with the ictal electroencephalographic activity disclosed 
on video-EEG (Di Bonaventura et al., 2009).  
In more heterogeneous case series, including patients with different types of seizures and 
status epilepticus, the degree of this concordance is significantly lower: in 12 patients with a 
single or a cluster of focal seizures with or without secondarily generalization, Raghavendra 
and colleagues described a 75% topographic concordance between reversible periictal MRI 
abnormalities and the electroclinical findings (Raghavendra et al., 2007); and in our own 
case series, using more strict topographic criteria, this concordance was only observed in 7 
out of 19 patients, with the others presenting several possible combinations between the 
clinical, MRI and electroencephalographic data: TPMA colocalized with 
electroencephalographic findings, with patients presenting generalized seizures; partial 
seizures concordant with focal electroencephalographic findings, with more widespread 
TPMA; partial seizures concordant with TPMA, with the electroencephalogram showing 
more diffuse abnormalities; focal TPMA, generalized seizures, and non-focal 
electroencephalographic abnormalities; colocalized electroencephalographic and clinical 
findings with “mirror-like” TPMA; and bilateral TPMA associated with diffuse 
electroencephalographic findings and generalized seizures  (Canas et al., 2010b).  
The broad electroclinical-imagiological spectrum that we and others describe can be mostly 
attributed to methodological and clinical factors (table 3). The degree of homogeneity of the 
clinical, imagiological and electroencephalographic data included for analysis seems to be a 
determinant methodological factor, with the inclusion of patients of different types of 
seizures/ status epilepticus and wide timings of MRI and electroencephalographic studies 
contributing to a lower level of concordance; conversely, a better concordance is associated 
with a short time-lag between the acquisition of these studies (figure 8) (Cole, 2004; Goyal et 
al., 2009; Huang et al., 2009). The topographic criteria used for concordance is also very 
relevant, with more broad criteria, considering concordant electroencephalographic and 
MRI findings lateralized to the probable seizure focus or admitting generalized seizures 
associated with focal MRI and electroencephalographic findings as probably generalized, 
increasing its level (Canas et al., 2010b). Sustained and prolonged focal seizures are also 
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highly colocalized with the MRI and electroencephalographic findings (figure 9) (Cole, 2004; 
Goyal et al., 2009; Huang et al., 2009), in opposition to a systemic seizure etiology, mostly 
due to its possible associated diffuse electroencephalographic abnormalities (Canas et al., 
2010).  
 
Methodological Clinical 
Homogeneity of the analyzed data  Seizure type and duration 
Time-lag between studies Seizure etiology 
Criteria for topographic concordance Seizure dynamics 
Table 3. Factors affecting the TPMA electroclinical-imagiological spectrum  
 
 
Fig. 8. 67 year-old male patient with post-stroke epilepsy. Hospitalized with recurrent motor 
seizures of the left-hemibody in the last 7 hours, triggered by low antiepileptic levels. The 
periictal MRI, obtained within 24 hours after seizure control, disclosed a DWI restriction in 
the periphery of an old encephaloclastic lesion (type 2B TPMA), which reversed on 
subsequent studies; the ictal electroencephalogram revealed a seizure-onset in right central 
region, characterized by rhythmic fast activity (arrow). The short time-lag between studies 
(ictal electroencephalogram, early postictal MRI) certainly contributed to the excellent 
electroclinical-imagiological topographic concordance observed in this case.    
Another factor that must be considered in the evaluation of the TPMA electroclinical-
imagiological spectrum is seizure dynamics. In fact, the rapid seizure propagation from a 
epileptic focus can contribute for the apparently non-concordant topographic findings that 
we described (Canas et al., 2010b): in patients presenting generalized seizures with focal 
colocalized electroencephalographic and MRI findings, the seizures most probably 
propagated from a epileptic focus defined by the results of those two exams, an hypothesis 
particularly conceivable in patients presenting structural cerebral abnormalities; when focal 
concordant clinical and electroencephalographic findings are associated with more 
widespread MRI abnormalities, the seizure focus is probably defined according to 
electroclinical criteria, with the more extensive TPMA resulting from the seizure 
propagation through neuronal pathways; and when the patients present partial seizures 
concordant with focal TPMA, with electroencephalograms showing more diffuse 
www.intechopen.com
 Neuroimaging – Clinical Applications 
 
202 
abnormalities (namely periodic lateralized or bilateral epileptiform discharges), the seizure 
focus is probably defined according to clinical and MRI criteria. The same seizure dynamics 
probably also justifies all cases of TPMA associated with remote or migratory signal changes 
and the cases with “mirror-like” TPMA. The determinant role of seizure dynamics to the 
electroclinical-imagiological spectrum of TPMA was also previously highlighted by other 
authors (Cole et al., 2004; Goyal et al, 2009).      
 
 
Fig. 9. 23 year-old female patient admitted with behavior abnormalities in the last 3 days. 
The ictal electroencephalogram showed slowing of the background activity over the left 
hemisphere and continuous spikes and sharp-waves over the left temporal region, 
compatible with complex partial status epilepticus. The periictal MRI (A), obtained 4 days 
after seizure control, disclosed swelling of the left hippocampal formation, with cortical 
hyperintensity on FLAIR and T2-weighted images (Type 1 TPMA); constitutional alterations 
of the brain are also seen, being the probable cause of the presenting status epilepticus. After 
5 months (B), the follow-up MRI showed reversion of the signal abnormalities; and after 19 
months (C) atrophy of the left hippocampus, with mild hyperintensity on T2 and FLAIR, 
suggestive of hippocampal sclerosis. In this case, in spite of a late periictal MRI, the 
sustained and prolonged status epilepticus contributed to the topographic concordance 
between the clinical, electroencephalographic and MRI findings.  
5. TPMA outcome 
In follow-up studies, the periictal MRI abnormalities attributable to seizures may totally 
reverse or induce irreversible brain damage. In this last situation, focal cortical laminar 
necrosis, T2 and/or FLAIR hyperintensities, atrophy and a decrease in N-acetyl-aspartate 
may be observed in the regions previously affected by TPMA, disclosing gliosis and 
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neuronal loss (Briellmann et al., 2002, 2005). These focal changes will eventually lead to a 
new seizure focus and the development of the novo focal epilepsy (Bartolomei et al., 1996; 
Parmar et al., 2006) or may coexist without any clinical or electroencephalographic evidence 
of chronic epilepsy (Chu et al., 2001; Senn et al., 2003). In our own series, we found an high 
incidence (63.2%) of clinical, MRI and electroencephalographic sequelae attributable to 
TPMA, with only small TPMA induced by systemic factors or tumor-like TPMA associated 
with a better outcome (Canas et al., 2010b); these TPMA sequelae were not only showed in 
patients with presenting seizures, but also in epileptic patients, with the appearance or 
aggravation of focal neurological deficits. However, we recognized that some confounding 
factors could have influenced our results, namely the high incidence of the novo epilepsy in 
patients with presenting seizure associated with structural brain lesions (small-vessel 
cerebrovascular disease, old encephaloclastic lesions), possibly the first seizures of a focal 
symptomatic epilepsy. 
At the periictal phase there are some TPMA characteristics that can help to predict their 
outcome. One of the most relevant is the type of edema disclosed on the DWI/ ADC studies: 
if TPMA are mainly composed of cytotoxic edema, the probability of inducing irreversible 
brain damage is higher, with the consequent topographically concordant clinical and 
electroencephalographic sequels (Canas et al., 2010b; Parmar et al., 2006); on the contrary, 
the TPMA mainly composed by vasogenic edema partially or totally reverse without any 
clinical or electroencephalographic consequence (Cohen-Gadol et al., 2004; Raghavendra et 
al., 2007; Canas et al., 2010a). TPMA affecting the temporal lobe, and particularly the mesial 
structures (hippocampus and amygdala) may also be associated with a worse outcome, 
possibly leading to the development of hippocampal sclerosis and the appearance of the 
novo epilepsy (Bartolomei et al., 1998; Juhazc et al., 1998; see also figure 9). The vulnerability 
of the temporal structures to seizures was demonstrated in the neuropathological analysis of 
patients dying from status epilepticus, with a substantial cell loss and gliosis in the 
hippocampus (Nixon et al., 2001; Pohlmann-Eden et al., 2006); some MRI signal 
abnormalities have been associated with the development of permanent hippocampal 
damage, mainly the presence of periictal cytotoxic edema and a lactate peak on protonic 
 
Analyzed data Analysis of Worse outcome Better outcome 
TPMA 
characteristics 
Predominant type of 
edema  
Cytotoxic  Vasogenic  
Location  Temporal  Extra-temporal 
Size 
Large cortico-
subcortical  
Small cortically 
restricted 
Type  Type 2B, type 2C Type 2A (tumor-like) 
Other MRI 
findings 
Associated structural 
cerebral disease 
Yes  No 
Clinical 
Type of seizures 
Status epilepticus, 
convulsive 
Single/ short 
seizures, non-
convulsive  
Etiology of presenting 
seizures 
Structural cerebral 
disease 
Systemic factors 
Preexisting epilepsy Yes  No 
Table 4. Proposed factors that may help to predict the TPMA outcome  
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MRS (Farina et al., 2004; Parmar et al., 2006), and a T2-weighted hyperintensity in the days 
following seizures (Provenzale et al., 2008). Finally, we demonstrated that the type of TPMA 
could help to predict their outcome, with large TPMA associated with remote lesions (type 
2C), TPMA in the periphery of cortical lesions (type 2C) and TPMA disclosed in patients 
with presenting seizures attributed to cerebral brain lesions associated with a higher 
likelihood of clinical, MRI and electroencephalographic sequels (Canas et al., 2010b).  
Based on the available literature and in our own experience, we propose the integrated 
analysis of some data for the prediction of TPMA outcome. These data, besides including 
the TPMA neuroimaging features, also consider other clinical and MRI findings (table 4). 
6. Pathophysiological mechanisms underlying TPMA formation and outcome  
Although the exact pathophysiological mechanisms underlying the seizure-induced MRI 
abnormalities are still not completely elucidated, the results of animal experiments and 
clinical observations obtained over the last years lead to a conceptual hypothesis, first 
proposed be Cole (Cole, 2004), and after supported by us and other authors (Canas et al., 
2010b). This hypothesis is based mostly on the capacity of certain brain regions to deal with 
the perfusion and energy demands triggered by seizure activity, which is determined by 
their intrinsic threshold; these hypothetical mechanisms, besides explaining some of the 
periictal MRI changes, could also help to clarify the TPMA electroclinical-imagiological 
spectrum, outcome, and some apparently contradictory findings described in the literature.   
The cortical hyperemia associated with provoked or spontaneous seizures is a common 
finding reported by neurosurgeons. Non-invasive methods, such as single-photon emission 
computed tomography, positron emission tomography, intracranial doppler and MR-
angiography, also disclosed that focal seizures are associated with high metabolic demands 
and a marked blood flow increase to the seizure focus (Juhazc et al., 1998; Theodore, 1999; 
Doherty et al., 2004). The corresponding hyperperfusion may disrupt the blood-brain barrier 
and justify the vasogenic edema and contrast enhancement observed in some cases 
(Wieshmann et al., 1997; Hong et al. 2004); that is supported by the prominent vascular 
congestion and perivascular hemosiderin deposition that was demonstrated in the rare cases 
of tumor-like TPMA that were biopsied (McClelland et al., 2005). When this increase in 
blood flow fails to compensate the focal glucose hypermetabolism, anaerobic metabolism 
takes place, with the released lactate originating a peak on MRS and contributing to a 
further damage of the blood-brain barrier. Animal models demonstrated that, if seizures are 
prolonged and/ or severe, an energy failure of the Na+/K+-ATPase pump may occur, with 
water and Na+ influx to the cell (Wang et al., 1996); this mechanism, so as an excessive 
release of glutamate (Sloviter et al., 1985) and an increased membrane ion permeability 
(McNamara, 1994), may all contribute to cytotoxic edema observed in some cases, with the 
corresponding neuronal dysfunction and/ or loss explaining the decreased N-acetyl-
aspartate level and the changes in choline and myoinositol observed in protonic MRS.  If 
this events are interrupted when the auto-regulatory vascular mechanisms still can 
compensate the high metabolic demands of seizure activity, the neuronal damage is 
minimized, which probably justifies the reversion of TPMA mainly composed of vasogenic 
edema (Wieshmann et al., 1997; Silverstein & Alexander, 1998; Cohen-Gadol et al., 2004; 
Hong et al., 2004); however, if seizure activity continues, irreversible brain damage may 
occur, justifying the worse clinical outcome of TPMA mainly composed of cytotoxic edema 
(Chu et al., 2001; Szabo et al., 2005; Parmar et al., 2006) or in which a lactate peak is revealed 
on MRS (Fazekas et al., 1995; Lazeyras et al., 2005). 
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This cascade of events occurring at the seizure focus certainly contributes to the frequently 
observed electroclinical-imagiological topographic concordance. In spite of this, a high 
incidence of focal TPMAs are found even when seizures are triggered/ provoked by 
systemic factors, are primarily generalized or are associated with diffuse EEG findings, 
contributing to the broad electroclinical-imagiological spectrum that we described (Canas et 
al., 2010b). We speculate that this can be attributed to the presence of brain regions 
intrinsically more susceptible to the TPMA pathophysiological mechanisms or to structural 
brain lesions that determine a lower seizure threshold. We show that in the presence of 
these lesions, TPMA are generally located in their periphery (type 2B TPMA), with 
topographically concordant EEG and clinical findings, suggesting that they may define the 
probable seizure focus. In the absence of these lesions, we and other authors show that 
TPMA are generally located in the posterior regions (occipital, parieto-occipital and 
temporo-occipital) (Chu et al., 2001; Kim et al., 2001, Canas et al., 2010b). The preponderance 
of TPMA in these regions could be attributed to their lower sympathetic innervation, 
making them more susceptible to the hyperperfusion induced by seizure activity, in a 
similar way to the cerebral lesions observed in reversible posterior leukoencephalopathy 
syndrome, with which TPMA share similar pathophysiological mechanisms and MRI signal 
abnormalities.  
7. Conclusion 
There is overwhelming evidence, obtained from animal experiments and human case 
reports, that acute seizures per se can induce brain damage and that MRI is a very powerful 
tool to its detection. In the clinical context where these MRI seizure-induced lesions 
generally appear the attending clinicians must be familiar not only with their neuroimaging 
features, but also with their electroclinical spectrum, allowing an accurate diagnosis. Since 
these seizure-induced MRI lesions are typically obtained fortuitously, several questions still 
remain without definite answer, namely which factors predispose only some patients to 
their development, what determine their different patterns, what are the exact 
physiopathological mechanisms underlying their formation or if the results of the periictal 
DWI and MRS studies can be reliable markers of epileptogenesis. To effectively answer 
these questions there is an urgent need for longitudinal multimodal MRI studies applied 
systematically in patients presenting with seizures.      
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